• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zentalis Pharmaceuticals Inc (NQ: ZNTL )

    3.320 +0.590 (+21.61%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,861,255
    Open 2.740
    Bid (Size) 3.160 (1)
    Ask (Size) 3.180 (10)
    Prev. Close 2.730
    Today's Range 2.710 - 3.340
    52wk Range 2.660 - 18.24
    Shares Outstanding 45,052,904
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
    The FDA has lifted the partial clinical hold on Zentalis Pharmaceuticals' azenosertib studies. Zentalis plans to work with trial investigators to continue development while presenting additional data... 
    Via Benzinga
    Exposures Product Safety
    Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL
    From Newman Ferrara LLP
    Via Business Wire

    Performance

    YTD
    -79.24%
    -79.24%
    1 Month
    +3.75%
    +3.75%
    3 Month
    -3.21%
    -3.21%
    6 Month
    -71.67%
    -71.67%
    1 Year
    -81.43%
    -81.43%

    More News

    Read More
    Zentalis Pharmaceuticals, Inc. (ZNTL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    (ZNTL) - Analyzing Zentalis Pharma's Short Interest
    Via Benzinga
    Analyst Expectations for Zentalis Pharma's Future
    Via Benzinga
    Where Zentalis Pharma Stands With Analysts
    Via Benzinga
    ZNTL Stock Earnings: Zentalis Pharma Misses EPS for Q2 2024
    Via InvestorPlace
    ZNTL Investors Have Opportunity to Join Zentalis Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Wall Street's Top 10 Stock Calls This Week - Saturday, June 22
    Via Talk Markets
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    ZNTL Stock Earnings: Zentalis Pharma Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
    Via Talk Markets
    Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
    From Immunome, Inc.
    Via Business Wire
    Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Around $108M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.